These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33665904)

  • 21. Change in glucose intolerance status and risk of incident cardiovascular disease: Tehran Lipid and Glucose Study.
    Kabootari M; Hasheminia M; Azizi F; Mirbolouk M; Hadaegh F
    Cardiovasc Diabetol; 2020 Mar; 19(1):41. PubMed ID: 32228577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance.
    Hu Y; Liu W; Chen Y; Zhang M; Wang L; Zhou H; Wu P; Teng X; Dong Y; Zhou Jw; Xu H; Zheng J; Li S; Tao T; Hu Y; Jia Y
    Acta Diabetol; 2010 Sep; 47(3):231-6. PubMed ID: 19760291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acarbose for the prevention of diabetes, hypertension, and cardiovascular disease in subjects with impaired glucose tolerance: the Study to Prevent Non-Insulin-Dependent Diabetes Mellitus (STOP-NIDDM) Trial.
    Chiasson JL
    Endocr Pract; 2006; 12 Suppl 1():25-30. PubMed ID: 16627376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abnormal glucose tolerance and increased risk for cardiovascular disease in Japanese-Americans with normal fasting glucose.
    Liao D; Shofer JB; Boyko EJ; McNeely MJ; Leonetti DL; Kahn SE; Fujimoto WY
    Diabetes Care; 2001 Jan; 24(1):39-44. PubMed ID: 11194238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormal glucose regulation in patients with acute ST- elevation myocardial infarction-a cohort study on 224 patients.
    Knudsen EC; Seljeflot I; Abdelnoor M; Eritsland J; Mangschau A; Arnesen H; Andersen GO
    Cardiovasc Diabetol; 2009 Jan; 8():6. PubMed ID: 19183453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alpha-glucosidase inhibitors for people with impaired glucose tolerance or impaired fasting blood glucose.
    Van de Laar FA; Lucassen PL; Akkermans RP; Van de Lisdonk EH; De Grauw WJ
    Cochrane Database Syst Rev; 2006 Oct; (4):CD005061. PubMed ID: 17054235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of chronic kidney disease in young adults with impaired glucose tolerance/impaired fasting glucose: a retrospective cohort study using electronic primary care records.
    Jadhakhan F; Marshall T; Ryan R; Gill P
    BMC Nephrol; 2018 Feb; 19(1):42. PubMed ID: 29482513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alanine-aminotransferase levels predict impaired glucose tolerance in a worksite population.
    Oberlinner C; Zober A; Nawroth PP; Humpert PM; Morcos M
    Acta Diabetol; 2010 Jun; 47(2):161-5. PubMed ID: 19855923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and validation of a risk-score model for subjects with impaired glucose tolerance for the assessment of the risk of type 2 diabetes mellitus-The STOP-NIDDM risk-score.
    Tuomilehto J; Lindström J; Hellmich M; Lehmacher W; Westermeier T; Evers T; Brückner A; Peltonen M; Qiao Q; Chiasson JL
    Diabetes Res Clin Pract; 2010 Feb; 87(2):267-74. PubMed ID: 20022651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention.
    Unwin N; Shaw J; Zimmet P; Alberti KG
    Diabet Med; 2002 Sep; 19(9):708-23. PubMed ID: 12207806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Prevalence of Osteoporosis Tested by Quantitative Computed Tomography in Patients With Different Glucose Tolerances.
    Li Y; Zhao Z; Wang L; Fu Z; Ji L; Wu X
    J Clin Endocrinol Metab; 2020 Jan; 105(1):. PubMed ID: 31545362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasminogen activator inhibitor (PAI-1) activity is elevated in Asian and Caucasian subjects with non-insulin-dependent (type 2) diabetes but not in those with impaired glucose tolerance (IGT) or non-diabetic Asians.
    Nagi DK; Mohamed Ali V; Jain SK; Walji S; Yudkin JS
    Diabet Med; 1996 Jan; 13(1):59-64. PubMed ID: 8741814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High prevalence of steroid-induced glucose intolerance with normal fasting glycaemia during low-dose glucocorticoid therapy: an oral glucose tolerance test screening study.
    Nowak KM; Rdzanek-Pikus M; Romanowska-Próchnicka K; Nowakowska-Płaza A; Papierska L
    Rheumatology (Oxford); 2021 Jun; 60(6):2842-2851. PubMed ID: 33254223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of Pre-Diabetes across Ethnicities: A Review of Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT) for Classification of Dysglycaemia.
    Yip WCY; Sequeira IR; Plank LD; Poppitt SD
    Nutrients; 2017 Nov; 9(11):. PubMed ID: 29165385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors during the early postpartum period for type 2 diabetes mellitus in women with gestational diabetes.
    Kawasaki M; Arata N; Sakamoto N; Osamura A; Sato S; Ogawa Y; Yasuhi I; Waguri M; Hiramatsu Y
    Endocr J; 2020 Apr; 67(4):427-437. PubMed ID: 31969529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of impaired fasting glycemia, impaired glucose tolerance, and type 2 diabetes in hemodialyzed patients when applying new diagnostic criteria.
    Elbert A; Schreier L; Galli C; Beresan H; Lopez G; Traversa M; Berg G
    J Ren Nutr; 2006 Oct; 16(4):300-3. PubMed ID: 17046613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The STOP-NIDDM Trial: an international study on the efficacy of an alpha-glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance: rationale, design, and preliminary screening data. Study to Prevent Non-Insulin-Dependent Diabetes Mellitus.
    Chiasson JL; Gomis R; Hanefeld M; Josse RG; Karasik A; Laakso M
    Diabetes Care; 1998 Oct; 21(10):1720-5. PubMed ID: 9773737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalences of type 2 diabetes, the insulin resistance syndrome, and coronary heart disease in an elderly, biethnic population.
    Lindeman RD; Romero LJ; Hundley R; Allen AS; Liang HC; Baumgartner RN; Koehler KM; Schade DS; Garry PJ
    Diabetes Care; 1998 Jun; 21(6):959-66. PubMed ID: 9614614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive value of HbA1c for incident diabetes among subjects with impaired glucose tolerance--analysis of the Indian Diabetes Prevention Programmes.
    Ramachandran A; Snehalatha C; Samith Shetty A; Nanditha A
    Diabet Med; 2012 Jan; 29(1):94-8. PubMed ID: 21790773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fasting plasma glucose as initial screening for diabetes and prediabetes in irish adults: The Diabetes Mellitus and Vascular health initiative (DMVhi).
    Sinnott M; Kinsley BT; Jackson AD; Walsh C; O'Grady T; Nolan JJ; Gaffney P; Boran G; Kelleher C; Carr B
    PLoS One; 2015; 10(4):e0122704. PubMed ID: 25874867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.